Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
hes2xenopus otic region 

Too many results?Too few results?

Experiment details for hes2

Sölter M et al. (2006) Assay

Characterization and function of the bHLH-O protein XHes2: insight into the mechanisms controlling retinal cell fate decision.

Gene Clone Species Stages Anatomy
hes2.L laevis NF stage 14 to NF stage 15 otic region

  Fig. 3. XHes2 is atypically regulated by XNgnr1 and Notch. (A) Real-time RT-PCR analysis of XHes2 expression in animal cap assays (equivalent stage=14/15) following XNgnr1 or Notch ICD overexpression. N-tubulin, ESR7 and ESR1 were used as controls for XNgnr1 and Notch ICD activities. Relative values are given as mean±s.e.m. of two (ESR1) or three (XHes2, ESR7, N-tubulin) independent experiments. (B-E) In situ hybridization analysis of XHes2 expression following injection of XNgnr1 (B,C) or Notch ICD (D,E) RNA. (B,C) XHes2 transcription is inhibited within its endogenous domains but activated ectopically within ectoderm and neuroectoderm (white arrowheads) (100%, n=12). (D,E) A weak ectopic expression of XHes2 is observed only along the lateral border of the neural plate (white arrowheads) (75%, n=12). Images correspond to dorsal views with anterior downwards. (C,E) Higher magnifications of areas shown in B,D. Abbreviations: is, injected side; st., developmental stage.